ACAA2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.742000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.591800E-01
Normal-vs-Stage2
5.927600E-01
Normal-vs-Stage3
2.607400E-01
Normal-vs-Stage4
5.494000E-01
Stage1-vs-Stage2
9.642800E-01
Stage1-vs-Stage3
4.434800E-01
Stage1-vs-Stage4
8.728600E-01
Stage2-vs-Stage3
2.558400E-01
Stage2-vs-Stage4
8.444800E-01
Stage3-vs-Stage4
2.880800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.385200E-01
Normal-vs-AfricanAmerican
6.966600E-01
Normal-vs-Asian
1.541610E-01
Caucasian-vs-AfricanAmerican
2.948800E-01
Caucasian-vs-Asian
6.822000E-02
AfricanAmerican-vs-Asian
3.866400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.730400E-01
Normal-vs-Female
7.731400E-01
Male-vs-Female
8.795600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.484000E-01
Normal-vs-Age(41-60Yrs)
9.795400E-01
Normal-vs-Age(61-80Yrs)
2.947400E-01
Normal-vs-Age(81-100Yrs)
6.649600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.711000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.377000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.340600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.237100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.108200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.609200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.076400E-01
Normal-vs-Daily Drinker
4.708400E-01
Normal-vs-Weekly Drinker
1.210050E-01
Normal-vs-Occasional Drinker
7.995200E-01
Normal-vs-Social Drinker
4.408000E-01
Non Drinker-vs-Daily Drinker
9.367200E-01
Non Drinker-vs-Weekly Drinker
4.958600E-01
Non Drinker-vs-Occasional Drinker
3.213900E-02
Non Drinker-vs-Social Drinker
3.374200E-01
Daily Drinker-vs-Weekly Drinker
4.713600E-01
Daily Drinker-vs-Occasional Drinker
2.738400E-02
Daily Drinker-vs-Social Drinker
2.459800E-01
Weekly Drinker-vs-Occasional Drinker
1.471580E-02
Weekly Drinker-vs-Social Drinker
1.319410E-01
Occasional Drinker-vs-Social Drinker
1.213780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.922600E-01
Normal-vs-Grade 2
4.196800E-01
Normal-vs-Grade 3
2.961400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.545600E-01
Grade 1-vs-Grade 3
9.881600E-01
Grade 1-vs-Grade 4
4.922600E-01
Grade 2-vs-Grade 3
4.672000E-01
Grade 2-vs-Grade 4
4.196800E-01
Grade 3-vs-Grade 4
2.961400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.243000E-01
Normal-vs-NonDiabetic
4.994800E-01
Diabetic-vs-NonDiabetic
5.513600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.182560E-01
Normal-vs-NoPancreatitis
5.072600E-01
Pancreatitis-vs-NoPancreatitis
1.245590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.569800E-01
Normal-vs-N1
6.217800E-01
N0-vs-N1
5.838200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.878030E-01
Normal-vs-TP53-NonMutant
3.279800E-01
TP53-Mutant-vs-TP53-NonMutant
5.535600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
